Investment in PrediSurge

Funding into PrediSurge allows for technological advancement.

Bremens Avocats was pleased to support investors LIFTT S.p.A., Crédit Agricole LHL Capital Innovation and UI Investissement – Metropoles Innovations in their investment in PrediSurge.

PrediSurge is a French company committed to developing a precision medicine platform for cardiovascular interventions. They aim to progress the safety of endovascular procedures providing numerical tools to physicians and Medtech companies.

This investment will push the growth for PrediSurge exponentially including expanding their international presence. This will increase sales allowing the company to broaden their audience of professionals to overall increased patient outcomes.

PrediSurge want their technology to be accessible to a vast majority as they dedicate this funding into their predictive software.

LIFTT S.p.A., Crédit Agricole LHL Capital Innovation and UI Investissement – Metropoles Innovations funds all across technologies and their main purpose is to support the development of commercialisation.

PrediSurge achieved a 6.5 Million Euro investment which will propel their technology drastically.

The legal advisory team included Bremens Avocats.